Article Text
PDF
Abstract
Intrathecal phenol neurolysis is a treatment of last resort for specific refractory cancer pains. However, there is a paucity of evidence in the academic literature and no recent documented evidence of repeat injections on the same patient. We aim to present our experience and learning from repeat interventions on the same patient in order to further the evidence base for medical professionals managing pain in a palliative care setting.
- Cancer
- Pain
Statistics from Altmetric.com
Footnotes
Contributors JMP and SY jointly conceived the notion of writing up this unusual case report and subsequent learnings. MP led data collection and write-up with expert support, assistance with editing and guidance from SY and CE. All authors discussed the results and contributed to the final manuscript.
Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.
Competing interests The authors have no conflicts of interest to declare. All co-authors have seen and agree with the contents of the manuscript and there is no financial interest to report. We certify that the submission is original work and is not under review at any other publication.
Provenance and peer review Not commissioned; internally peer-reviewed.